Christopher Cann
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Colorectal Cancer Screening and Detection
- Cutaneous Melanoma Detection and Management
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 15
- Colorectal Cancer Treatments and Studies 7
- Cancer Immunotherapy and Biomarkers 3
- Colorectal Cancer Surgical Treatments 3
- Global Cancer Incidence and Screening 2
-
- Cancer Genomics and Diagnostics 3
- Co-authors
- Cathy Eng (7 shared papers)Takayuki Yoshino (1 shared paper)Brittany O’Brian (1 shared paper)Rodrigo Oliva Perez (1 shared paper)Chiara Cremolini (1 shared paper)Amala Benny (1 shared paper)Erika Ruíz‐García (1 shared paper)Kristen K. Ciombor (1 shared paper)
- Journals
- The Oncologist (4 papers)Clinical Cancer Research (2 papers)The Lancet (1 paper)Journal of Surgical Oncology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Christopher Cann
16 papers receiving 578 citations
Christopher Cann's Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 344
- Cancer Research 76
- Pulmonary and Respiratory Medicine 45
- Molecular Biology 87
- Toxicology 5
Countries citing papers authored by Christopher Cann
This map shows the geographic impact of Christopher Cann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Cann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Cann more than expected).
Fields of papers citing papers by Christopher Cann
This network shows the impact of papers produced by Christopher Cann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Cann. The network helps show where Christopher Cann may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Cann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Colorectal cancer Hit paper breakdown → | 2024 | 244 |
| 2 | 2021 | 143 | |
| 3 | 2022 | 46 | |
| 4 | 2023 | 44 | |
| 5 | 2021 | 24 | |
| 6 | 2020 | 20 | |
| 7 | 2022 | 18 | |
| 8 | 2021 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 2023 | 7 | |
| 11 | 2022 | 6 | |
| 12 | 2025 | 3 | |
| 13 | 2019 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 | |
| 19 | 2026 | 0 | |
| 20 | 2026 | 0 |
About Christopher Cann
Christopher Cann is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 21 papers that have together received 585 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Cancer Genomics and Diagnostics (3 papers), Global Cancer Incidence and Screening (2 papers), Gastric Cancer Management and Outcomes (2 papers), Melanoma and MAPK Pathways (2 papers) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Oncology (344 citations), Cancer Research (76 citations), Pulmonary and Respiratory Medicine (45 citations), Molecular Biology (87 citations) and Toxicology (5 citations). Christopher Cann has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Cathy Eng, Takayuki Yoshino, Brittany O’Brian, Rodrigo Oliva Perez, Chiara Cremolini, Amala Benny, Erika Ruíz‐García, Kristen K. Ciombor, Wade Thomas Iams and Christine Marie Lovly. Their work appears in journals such as The Oncologist, Clinical Cancer Research, The Lancet, Journal of Surgical Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.